MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0004405
Prravi Pharmaceuticals Private Limited
Prravi Pharmaceuticals Private Limited - chemicals in Patna, Bihar, India. Directors, charges & compliance details.
Revenue · FY 2024
₹11.62 Lakh
▼ 46% YoY
Net loss · FY 2024
₹44,216
Net margin -3.8%
EBITDA · FY 2024
₹69,665
EBITDA margin 6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3.5 Lakh
Issued & subscribed
Open charges
₹8 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
7
Provident fund records
About Prravi Pharmaceuticals Private Limited
Data last updated:
Prravi Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24200BR2020PTC046582.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors including Vishnu Kant Sahay and Ritesh Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kaushalya Bhawan Purandarpur, Patna, Bihar, India – 800001.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.62 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net loss of ₹44,216 (net margin -3.8%) and EBITDA of ₹69,665 (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
Prravi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0004405).
Company details
CIN U24200BR2020PTC046582
Registration Number 046582
Incorporation Date 02 July 2020
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0004405
Recognitions & Rankings of Prravi Pharmaceuticals
Contact details
Prravi Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered AddressKaushalya Bhawan Purandarpur, Patna, Bihar, India – 800001
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Prravi Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prravi Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Prravi Pharmaceuticals Private Limited, buy the company report.
Financials of Prravi Pharmaceuticals Private Limited
FY 2025 filings availablePrravi Pharmaceuticals Private Limited reported revenue of ₹11.62 Lakh (down 46% YoY) for FY 2024.
Revenue · FY 2024
₹11.62 Lakh ▼ 46%
Net loss · FY 2024
₹44,216 margin -3.8%
EBITDA · FY 2024
₹69,665 margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 46%
3 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 74%
Revenue fell 46% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹69,665 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹44,216 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6% | |||
| Net Profit Margin | -3.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Prravi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prravi Pharmaceuticals Private Limited
Prravi Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnu Kant Sahay | Director | 29 Aug 2023 | 3 Years 2 Months | Current |
| Ritesh Sahay | Director | 02 Jul 2020 | 6 Years 3 Months | Current |
| Rana Alokjee Sahay | Director | 02 Jul 2020 | 6 Years 3 Months | Current |
Charges & borrowings
Open charges
₹8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2022 | 100630199 | Canara Bank | ₹8 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Prravi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prravi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Prravi Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Prravi Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Pratiksha ceased to be Director on 30 Aug 2023.
AGM
Prravi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Prravi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Ceased
Pratiksha ceased to be Director.
Appointed
Vishnu Kant Sahay was appointed as Director.
Charges
A charge with Canara Bank amounted to Rs. 8.00 Lakh with Charge ID 100630199 was registered on 28 Oct 2022.
Appointed
Rana Alokjee Sahay was appointed as Director.
Appointed
Ritesh Sahay was appointed as Director.
Incorporation
02 Jul 2020
Prravi Pharmaceuticals Private Limited was registered on 02 Jul 2020 with Roc Patna & aged 6 years 4 months as per MCA records.
Frequently asked questions
Prravi Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 July 2020 (6+ years old) and is registered under CIN U24200BR2020PTC046582.
Prravi Pharmaceuticals has 3 current directors:
- Vishnu Kant Sahay - Director
- Ritesh Sahay - Director
- Rana Alokjee Sahay - Director
The latest financial statements of Prravi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Prravi Pharmaceuticals is U24200BR2020PTC046582. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prravi Pharmaceuticals was incorporated on 02 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Patna.
Pratiksha ceased to be Director on 30 Aug 2023. Vishnu Kant Sahay was appointed as Director on 29 Aug 2023. Rana Alokjee Sahay was appointed as Director on 02 Jul 2020. Prravi Pharmaceuticals has 4 board changes on record in total.
Yes, Prravi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0004405).
The registered office of Prravi Pharmaceuticals is at Kaushalya Bhawan Purandarpur, Patna, Bihar, India – 800001.
Prravi Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Prravi Pharmaceuticals has open charges of ₹8 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages